TES-991 is a novel, potent and selective inhibitor of human α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) with an IC50 of 3 nM. TES-991 protected mouse liver cells in a model of non-alcoholic fatty liver disease.